These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 18648963

  • 1. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
    Crew KD, Capodice JL, Greenlee H, Apollo A, Jacobson JS, Raptis G, Blozie K, Sierra A, Hershman DL.
    J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
    [Abstract] [Full Text] [Related]

  • 2. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
    Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL.
    J Clin Oncol; 2010 Mar 01; 28(7):1154-60. PubMed ID: 20100963
    [Abstract] [Full Text] [Related]

  • 3. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
    Oh B, Kimble B, Costa DS, Davis E, McLean A, Orme K, Beith J.
    Acupunct Med; 2013 Sep 01; 31(3):264-71. PubMed ID: 23722951
    [Abstract] [Full Text] [Related]

  • 4. Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial.
    Zou X, Chen ZY, Yang YH, Qiao Y, He SJ, Li Q, Chen WL, Zhang XY, Li SY, Sha SY, Hu MH, Zhang XY, Yang MJ, Wang RP, Wu HG, Shi Y, Xue XH, Ji YJ.
    Integr Cancer Ther; 2023 Sep 01; 22():15347354231188679. PubMed ID: 37565358
    [Abstract] [Full Text] [Related]

  • 5. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD.
    JAMA; 2018 Jul 10; 320(2):167-176. PubMed ID: 29998338
    [Abstract] [Full Text] [Related]

  • 6. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
    Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan X, Belury M, Cole R, Logan A, Layman R, Ramaswamy B, Wesolowski R, Berger M, Patterson E, Loprinzi C, Shapiro CL, Yee L.
    Breast Cancer Res Treat; 2018 Feb 10; 167(3):709-718. PubMed ID: 29101597
    [Abstract] [Full Text] [Related]

  • 7. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
    Chen L, Lin CC, Huang TW, Kuan YC, Huang YH, Chen HC, Kao CY, Su CM, Tam KW.
    Breast; 2017 Jun 10; 33():132-138. PubMed ID: 28384564
    [Abstract] [Full Text] [Related]

  • 8. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
    Swenson KK, Nissen MJ, Henly SJ, Maybon L, Pupkes J, Zwicky K, Tsai ML, Shapiro AC.
    Oncol Nurs Forum; 2013 Nov 10; 40(6):549-57. PubMed ID: 24161633
    [Abstract] [Full Text] [Related]

  • 9. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A, Heydarian R, Ochoa C, Dwivedi AK, Nahleh ZA.
    Breast J; 2018 May 10; 24(3):260-268. PubMed ID: 29442401
    [Abstract] [Full Text] [Related]

  • 10. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
    Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J.
    J Clin Oncol; 2015 Apr 01; 33(10):1104-11. PubMed ID: 25452437
    [Abstract] [Full Text] [Related]

  • 11. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, Greenlee H, Lew DL, Minasian LM, Till C, Wade JL, Meyskens FL, Moinpour CM.
    J Clin Oncol; 2015 Jun 10; 33(17):1910-7. PubMed ID: 25940724
    [Abstract] [Full Text] [Related]

  • 12. Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.
    Martinez JA, Wertheim BC, Roe DJ, Chalasani P, Cohen J, Baer L, Chow HS, Stopeck AT, Thompson PA.
    Breast Cancer Res Treat; 2022 Feb 10; 192(1):113-122. PubMed ID: 35039952
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.
    Hershman DL, Unger JM, Greenlee H, Capodice J, Lew DL, Darke A, Minasian LM, Fisch MJ, Henry NL, Crew KD.
    JAMA Netw Open; 2022 Nov 01; 5(11):e2241720. PubMed ID: 36367721
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H, Crew KD, Shao T, Kranwinkel G, Kalinsky K, Maurer M, Brafman L, Insel B, Tsai WY, Hershman DL.
    Support Care Cancer; 2013 Apr 01; 21(4):1077-87. PubMed ID: 23111941
    [Abstract] [Full Text] [Related]

  • 15. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
    Peng N, Yu M, Yang G, Fu Q, Xu Y, Yu J, Liu Q, Li C, Xu W, Zhang Y, Ma C, Yang L, Yu R, Wang X.
    Breast; 2018 Feb 01; 37():18-27. PubMed ID: 29059538
    [Abstract] [Full Text] [Related]

  • 16. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
    Galantino ML, Callens ML, Cardena GJ, Piela NL, Mao JJ.
    Altern Ther Health Med; 2013 Feb 01; 19(6):38-44. PubMed ID: 24254037
    [Abstract] [Full Text] [Related]

  • 17. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.
    Sheng JY, Blackford AL, Bardia A, Venkat R, Rosson G, Giles J, Hayes DF, Jeter SC, Zhang Z, Hayden J, Nguyen A, Storniolo AM, Tarpinian K, Henry NL, Stearns V.
    Breast Cancer Res Treat; 2019 Aug 01; 176(3):617-624. PubMed ID: 31079282
    [Abstract] [Full Text] [Related]

  • 18. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
    Martínez N, Herrera M, Frías L, Provencio M, Pérez-Carrión R, Díaz V, Morse M, Crespo MC.
    Clin Transl Oncol; 2019 Apr 01; 21(4):489-498. PubMed ID: 30293230
    [Abstract] [Full Text] [Related]

  • 19. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL.
    Clin Breast Cancer; 2018 Apr 01; 18(2):168-174.e2. PubMed ID: 29361424
    [Abstract] [Full Text] [Related]

  • 20. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
    Chim K, Xie SX, Stricker CT, Li QS, Gross R, Farrar JT, DeMichele A, Mao JJ.
    BMC Cancer; 2013 Sep 03; 13():401. PubMed ID: 24004677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.